亚洲国产欧美精品一区二区三区,亚洲欧美在线免费观看,51国产午夜精品免费视频,欧美特黄视频在线观看,日韩欧美精品在线视频,99视频精品国在线视频艾草,97精品视频在线观看视频app,久久99精品久久久久久,久久精品99久久香蕉国产色戒

<dl id="k68ci"></dl>

<abbr id="k68ci"><fieldset id="k68ci"></fieldset></abbr>

<rt id="k68ci"><tr id="k68ci"></tr></rt>

Research and Development 科研管線

納基奧侖賽認(rèn)證醫(yī)療機(jī)構(gòu)名單創(chuàng)新支付研發(fā)管線學(xué)術(shù)發(fā)表

發(fā)表時(shí)間：2024/12/07 來源：Blood - 2024 ASH Annual Meeting Abstract

Development of a Novel Allogeneic Super-γδ T Cell Therapy for Acute Myeloid Leukemia and Multiple Tumors
發(fā)表時(shí)間：2024/12/05 來源：Blood - 2024 ASH Annual Meeting Abstract

Efficacy and Safety of Inaticabtagene Autoleucel in Children with Relapsed/Refractory (R/R) B-cell Acute Lymphoblastic Leukemia in China
發(fā)表時(shí)間：2024/12/03 來源：Blood Advances

Inaticabtagene Autoleucel (CNCT19) in Adult Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
發(fā)表時(shí)間：2024/11/05 來源：Blood - 2024 ASH Annual Meeting Abstract

CD19 CAR T-Cell Therapy in Refractory Autoimmune Hemolytic Anemia
發(fā)表時(shí)間：2024/11/05 來源：Blood - 2024 ASH Annual Meeting Abstract

Development of Allogeneic Dual-Targeting CD19/BCMA CAR-T Cell Therapeutics Using ALL-IN-ONE Site-Specific Integration Technology for Autoimmune Diseases
發(fā)表時(shí)間：2024/11/05 來源：Blood - 2024 ASH Annual Meeting Abstract

Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: An Updated Report on the Pivotal Study of Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-Cell ALL) in China

1 2 3 4

我們的目標(biāo) 專注細(xì)胞治療領(lǐng)航健康未來

<dl id="4w8ee"></dl>